Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Basal Ganglia
12%
Blinking
8%
Blood Flow
8%
Brain Structure
7%
Cerebral Blood Flow
5%
Chronic Tic Disorder
12%
D2 Receptor
16%
Deep Brain Stimulation
6%
Dopamine
19%
Dopamine Agonist
6%
Dopamine D2 Receptor (DRD2)
10%
Flow Response
8%
Focal Dystonia
5%
Functional Magnetic Resonance Imaging
14%
Functional Tics
7%
Healthy Controls
5%
Hippocampal Volume
6%
Image Registration
5%
Levodopa
31%
Magnetic Resonance Imaging
8%
Movement Disorders
8%
Neuroimaging
16%
Obesity
6%
Parkinson Patients
9%
Parkinson's Disease
45%
Parkinson's Disease Psychosis
6%
Parkinsonism
9%
Pathophysiology
10%
Pediatric
6%
Pharmacodynamics
7%
Pharmacological MRI (phMRI)
7%
Placebo
8%
Positron Emission Tomography
12%
Provisional Tic Disorder
13%
Psychosis
6%
Putamen
11%
Radioligand
6%
Randomized Placebo-controlled Trial
6%
Receptor Binding
11%
Regional Cerebral Blood Flow (rCBF)
16%
Specific Binding
6%
Striatal
10%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
8%
Template Image
6%
Tic Disorders
39%
Tic Severity
9%
Tic Suppression
18%
Tourette Syndrome
100%
Type 1 Diabetes Mellitus (T1DM)
6%
Type I Diabetes
6%
Neuroscience
Agonist
7%
Arterial Spin Labeling
5%
Basal Ganglia
12%
Behavior (Neuroscience)
10%
Body Mass Index
6%
Comorbidity
5%
Deep Brain Stimulation
11%
DNA Template
6%
Dopamine Agonist
6%
Dopamine Receptor D2
8%
Dopaminergic
7%
Dystonia
11%
Fluorine-18
6%
Functional Connectivity
5%
Functional Magnetic Resonance Imaging
17%
Hyperglycemia
5%
Hypoglycemia
6%
In Vivo
7%
L-DOPA
29%
Magnetic Resonance Imaging
12%
Magnetic Resonance Imaging
9%
Parkinson's Disease
50%
Parkinsonism
9%
Placebo
13%
Positron Emission Tomography
15%
Positron Emission Tomography
9%
Putamen
11%
Radioligand
6%
Receptor
12%
Receptor Binding
11%
Stereotypic Movement Disorder
8%
Subthalamic Nucleus
7%
Thalamus
10%
Tic Disorder
48%
Tourette Syndrome
74%